Relevant molecular markers and targets

по Darcy, Kathleen M.
Опубликовано 2006

Translational Research in the Gynecologic Oncology Group: Evaluation of Ovarian Cancer Markers, Profiles and Novel Therapies

по Darcy, Kathleen M., Birrer, Michael J.
Опубликовано 2010

Population analysis of a 24-h paclitaxel infusion in advanced endometrial cancer: a gynaecological oncology group study

по Mould, Diane R, Fleming, Gini F, Darcy, Kathleen M, Spriggs, David
Опубликовано 2006

Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

по Havrilesky, Laura J., Alvarez Secord, Angeles, Darcy, Kathleen M., Armstrong, Deborah K., Kulasingam, Shalini
Опубликовано 2008

Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer

по Marcus, Charlotte S, Maxwell, G Larry, Darcy, Kathleen M, Hamilton, Chad A, McGuire, William P
Опубликовано 2014

Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro

по Paucarmayta, Ana, Taitz, Hannah, McGlorthan, Latoya, Casablanca, Yovanni, Maxwell, G. Larry, Darcy, Kathleen M., Syed, Viqar
Опубликовано в: Biomedicines (2020)

Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?

по Chow, Stephanie, Wong, Deanna, Liao, Cheng-I, Mann, Amandeep, Tian, Chunqiao, Darcy, Kathleen M., Chan, John K.
Опубликовано в: J Gynecol Oncol (2020)

Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer

по He, Xiaolong, Arslan, Ahmet Dirim, Pool, Mark D., Ho, Tsui-Ting, Darcy, Kathleen M., Coon, John S., Beck, William T.
Опубликовано 2010

PHASE II CLINICAL TRIAL OF CAPECITABINE IN THE TREATMENT OF ADVANCED, PERSISTENT OR RECURRENT SQUAMOUS CELL CARCINOMA OF THE CERVIX WITH TRANSLATIONAL RESEARCH: A GYNECOLOGIC ONCOL...

по Garcia, Agustin A., Blessing, John A., Darcy, Kathleen M., Lenz, Heinz Josef, Zhang, Wu, Hannigan, Ed, Moore, David H.
Опубликовано 2006

A PHASE II TRIAL OF THALIDOMIDE IN PATIENTS WITH REFRACTORY ENDOMETRIAL CANCER AND CORRELATION WITH ANGIOGENESIS BIOMARKERS: A GYNECOLOGIC ONCOLOGY GROUP STUDY

по McMeekin, D. Scott, Sill, Michael W., Benbrook, Doris, Darcy, Kathleen M., Stearns-Kurosawa, Deborah J., Eaton, Lynne, Yamada, S. Diane
Опубликовано 2007

Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells

по Teng, Pang-ning, Bateman, Nicholas W., Darcy, Kathleen M., Hamilton, Chad A., Maxwell, George Larry, Bakkenist, Christopher J., Conrads, Thomas P.
Опубликовано в: Gynecol Oncol (2015)

Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum

по DeLoia, Julie A., Bhagwat, Nikhil R., Darcy, Kathleen M., Strange, Mary, Tian, Chunquio, Nuttall, Kevin, Krivak, Thomas C., Niedernhofer, Laura J.
Опубликовано 2012

Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Pa...

по Krivak, Thomas C., Darcy, Kathleen M., Tian, Chunqiao, Armstrong, Deborah, Baysal, Bora E., Gallion, Holly, Ambrosone, Christine B., DeLoia, Julie A.
Опубликовано в: J Clin Oncol (2008)

Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group stu...

по Darcy, Kathleen M., Brady, William E., Blancato, Jan K., Dickson, Robert B., Hoskins, William J., McGuire, William P., Birrer, Michael J.
Опубликовано в: Gynecol Oncol (2009)

Phase III Trial to Evaluate the Efficacy of Maintaining Hemoglobin Levels above 120 G/DL with Erythropoietin vs above 100 G/DL without Erythropoietin in Anemic Patients Receiving C...

по Thomas, Gillian, Ali, Shamshad, Hoebers, Frank JP, Darcy, Kathleen M, Rodgers, William H, Patel, Malti, Abulafia, Ovardia, Lucci, Joseph A., Begg, Adrian C.
Опубликовано 2007

Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group St...

по Tian, Chunqiao Q., Darcy, Kathleen M., Krivak, Thomas C., DeLoia, Julie A., Armstrong, Deborah, Davis, Warren, Zhao, Hua, Moysich, Kirsten, Ambrosone, Christine B.
Опубликовано 2013

High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer

по Veneris, Jennifer Taylor, Darcy, Kathleen M., Mhawech-Fauceglia, Paulette, Tian, Chunqiao, Lengyel, Ernst, Lastra, Ricardo R., Pejovic, Tanja, Conzen, Suzanne D., Fleming, Gini F.
Опубликовано в: Gynecol Oncol (2017)

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

по Randall, Leslie M., Monk, Bradley J., Darcy, Kathleen M., Tian, Chunqiao, Burger, Robert A., Liao, Shu-Yuan, Peters, William A., Stock, Richard J., Fruehauf, John P.
Опубликовано 2008

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

по Aghajanian, Carol, Sill, Michael W., Darcy, Kathleen M., Greer, Benjamin, McMeekin, D. Scott, Rose, Peter G., Rotmensch, Jacob, Barnes, Mack N., Hanjani, Parviz, Leslie, Kimberly K.
Опубликовано 2011

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persiste...

по Usha, Lydia, Sill, Michael W., Darcy, Kathleen M., Benbrook, Doris M., Hurteau, Jean A, Michelin, David P., Mannel, Robert S., Hanjani, Parviz, De Geest, Koen, Godwin, Andrew K.
Опубликовано 2011